Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Translation and Validation of the Persian Version of the Scleroderma Health Assessment Questionnaire (Shaq) Publisher Pubmed



Nayebirad S1 ; Emamzade A2 ; Sedaghat M3 ; Montazeri A4 ; Gharibdoost F2 ; Yaseri M5 ; Tamartash Z2 ; Salehi S2 ; Kiani T2 ; Soltani S2 ; Mohammadzadegan A2 ; Eshaghi A2 ; Madanipour MR2 ; Atef Yekta R6, 7 Show All Authors
Authors
  1. Nayebirad S1
  2. Emamzade A2
  3. Sedaghat M3
  4. Montazeri A4
  5. Gharibdoost F2
  6. Yaseri M5
  7. Tamartash Z2
  8. Salehi S2
  9. Kiani T2
  10. Soltani S2
  11. Mohammadzadegan A2
  12. Eshaghi A2
  13. Madanipour MR2
  14. Atef Yekta R6, 7
  15. Kavosi H2, 6
Show Affiliations
Authors Affiliations
  1. 1. Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Rheumatology Research Center, Tehran University of Medical Science (TUMS), Tehran, 1411713137, Iran
  3. 3. Department of Community Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Population Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
  5. 5. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Pain Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Anesthesiology and Critical Care, Tehran University of Medical Sciences, Dr. Ali Shariati HospitalKaregar Shomali Ave, Tehran, 14117-13135, Iran

Source: Internal and Emergency Medicine Published:2023


Abstract

The present study aimed to translate and validate the Scleroderma Health Assessment Questionnaire (SHAQ) for Persian-speaking patients (SHAQ-P), using a cross-sectional study. This cross-sectional study included SSc patients with 2013 ACR/EULAR criteria. The SHAQ was translated using a forward–backward method. HAQ-DI and SSc-HAQ scores were calculated from the patient-answered questionnaires. Rheumatology experts assessed the face and content validities of the SHAQ-P. Psychometric properties of the SHAQ-P were then assessed: Structural validity was analyzed using principal component factor analysis. Discriminant and convergent validities were measured on subgroups of the initial patient population. Test–retest reliability was measured on patients who filled the SHAQ-P again after 1 month. The Scale-CVI-average (S-CVI/Ave) score for content validity was 88.7%. Face validity was measured to be 68.17% using the QQ10 questionnaire. Factor analysis revealed a two-factor structure with 20 out of 26 questions loading on the first factor (N = 285). One-way ANOVA showed that patients with a higher number of involved organs had higher average HAQ-DI and SSc-HAQ-scores (N = 60, P = 0.019 and 0.023, respectively). HAQ-DI and SSc-HAQ-scores were significantly correlated with the physical component score of SF36 (N = 31, correlation coefficient = – 0.65 and – 0.72, respectively). Reliability testing after one month demonstrated that HAQ-DI and SSc-HAQ-scores were significantly correlated with their initial (N = 40, correlation coefficient = 0.86 and 0.84, respectively), proving that the Persian SHAQ was a valid and reliable questionnaire to evaluate scleroderma patients' quality of life. © 2023, The Author(s), under exclusive licence to Societa Italiana di Medicina Interna (SIMI).